Development of a nanobody-based lateral flow immunoassay for detection of human norovirus

We previously identified a Nanobody (termed Nano-85) that bound to a highly conserved region on the norovirus capsid. In this study, the Nanobody was biotinylated and gold conjugated for a lateral flow immunoassay (termed Nano-IC). We showed that the Nano-IC assay was capable of detecting at least f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Doerflinger, Sylvie (VerfasserIn) , Tabatabai, Julia (VerfasserIn) , Schnitzler, Paul (VerfasserIn) , Koromyslova, Anna D. (VerfasserIn) , Hansman, Grant S. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 October 2016
In: mSphere
Year: 2016, Jahrgang: 1, Heft: 5
ISSN:2379-5042
DOI:10.1128/mSphere.00219-16
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1128/mSphere.00219-16
Verlag, kostenfrei, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061999/
Volltext
Verfasserangaben:Sylvie Y. Doerflinger, Julia Tabatabai, Paul Schnitzler, Carlo Farah, Steffen Rameil, Peter Sander, Anna Koromyslova, Grant S. Hansman

MARC

LEADER 00000caa a2200000 c 4500
001 1566831946
003 DE-627
005 20240316100313.0
007 cr uuu---uuuuu
008 180103s2016 xx |||||o 00| ||eng c
024 7 |a 10.1128/mSphere.00219-16  |2 doi 
035 |a (DE-627)1566831946 
035 |a (DE-576)496831941 
035 |a (DE-599)BSZ496831941 
035 |a (OCoLC)1340985643 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Doerflinger, Sylvie  |e VerfasserIn  |0 (DE-588)1135936560  |0 (DE-627)890949999  |0 (DE-576)490183301  |4 aut 
245 1 0 |a Development of a nanobody-based lateral flow immunoassay for detection of human norovirus  |c Sylvie Y. Doerflinger, Julia Tabatabai, Paul Schnitzler, Carlo Farah, Steffen Rameil, Peter Sander, Anna Koromyslova, Grant S. Hansman 
264 1 |c 12 October 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.01.2018 
520 |a We previously identified a Nanobody (termed Nano-85) that bound to a highly conserved region on the norovirus capsid. In this study, the Nanobody was biotinylated and gold conjugated for a lateral flow immunoassay (termed Nano-IC). We showed that the Nano-IC assay was capable of detecting at least four antigenically distinct GII genotypes, including the newly emerging GII.17. In the clinical setting, the Nano-IC assay had sensitivities equivalent to other commercially available lateral flow systems. The Nano-IC method was capable of producing results in ~5 min, which makes this method useful in settings that require rapid diagnosis, such as cruise ship outbreaks and elder care facilities. The Nano-IC assay has several advantages over antibody-based IC methods: for example, Nanobodies can be readily produced in large quantities, they are generally more stable than conventional antibodies, and the Nanobody binding sites can be easily obtained by X-ray crystallography., Human noroviruses are the dominant cause of outbreaks of acute gastroenteritis. These viruses are usually detected by molecular methods, including reverse transcriptase PCR (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Human noroviruses are genetically and antigenically diverse, with two main genogroups that are further subdivided into over 40 different genotypes. During the past decade, genogroup 2 genotype 4 (GII.4) has dominated in most countries, but recently, viruses belonging to GII.17 have increased in prevalence in a number of countries. A number of commercially available ELISAs and lateral flow immunoassays were found to have lower sensitivities to the GII.17 viruses, indicating that the antibodies used in these methods may not have a high level of cross-reactivity. In this study, we developed a rapid Nanobody-based lateral flow immunoassay (Nano-immunochromatography [Nano-IC]) for the detection of human norovirus in clinical specimens. The Nano-IC assay detected virions from two GII.4 norovirus clusters, which included the current dominant strain and a novel variant strain. The Nano-IC method had a sensitivity of 80% and specificity of 86% for outbreak specimens. Norovirus virus-like particles (VLPs) representing four genotypes (GII.4, GII.10, GII.12, and GII.17) could be detected by this method, demonstrating the potential in clinical screening. However, further modifications to the Nano-IC method are needed in order to improve this sensitivity, which may be achieved by the addition of other broadly reactive Nanobodies to the system., IMPORTANCE We previously identified a Nanobody (termed Nano-85) that bound to a highly conserved region on the norovirus capsid. In this study, the Nanobody was biotinylated and gold conjugated for a lateral flow immunoassay (termed Nano-IC). We showed that the Nano-IC assay was capable of detecting at least four antigenically distinct GII genotypes, including the newly emerging GII.17. In the clinical setting, the Nano-IC assay had sensitivities equivalent to other commercially available lateral flow systems. The Nano-IC method was capable of producing results in ~5 min, which makes this method useful in settings that require rapid diagnosis, such as cruise ship outbreaks and elder care facilities. The Nano-IC assay has several advantages over antibody-based IC methods: for example, Nanobodies can be readily produced in large quantities, they are generally more stable than conventional antibodies, and the Nanobody binding sites can be easily obtained by X-ray crystallography. 
700 1 |a Tabatabai, Julia  |d 1984-  |e VerfasserIn  |0 (DE-588)1070023892  |0 (DE-627)823195147  |0 (DE-576)429705425  |4 aut 
700 1 |a Schnitzler, Paul  |d 1959-  |e VerfasserIn  |0 (DE-588)1022905643  |0 (DE-627)717329798  |0 (DE-576)366155695  |4 aut 
700 1 |a Koromyslova, Anna D.  |e VerfasserIn  |0 (DE-588)113528248X  |0 (DE-627)890241414  |0 (DE-576)489738842  |4 aut 
700 1 |a Hansman, Grant S.  |e VerfasserIn  |0 (DE-588)105917703X  |0 (DE-627)798127287  |0 (DE-576)325655553  |4 aut 
773 0 8 |i Enthalten in  |t mSphere  |d Washington, DC : American Society for Microbiology, 2016  |g 1(2016,5) Artikel-Nummer e00219-16, 6 Seiten  |h Online-Ressource  |w (DE-627)845748807  |w (DE-600)2844248-9  |w (DE-576)454092903  |x 2379-5042  |7 nnas  |a Development of a nanobody-based lateral flow immunoassay for detection of human norovirus 
773 1 8 |g volume:1  |g year:2016  |g number:5  |a Development of a nanobody-based lateral flow immunoassay for detection of human norovirus 
856 4 0 |u http://dx.doi.org/10.1128/mSphere.00219-16  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061999/  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180103 
993 |a Article 
994 |a 2016 
998 |g 105917703X  |a Hansman, Grant S.  |m 105917703X:Hansman, Grant S.  |d 910000  |d 911700  |e 910000PH105917703X  |e 911700PH105917703X  |k 0/910000/  |k 1/910000/911700/  |p 8  |y j 
998 |g 113528248X  |a Koromyslova, Anna D.  |m 113528248X:Koromyslova, Anna D.  |p 7 
998 |g 1022905643  |a Schnitzler, Paul  |m 1022905643:Schnitzler, Paul  |d 910000  |d 911700  |e 910000PS1022905643  |e 911700PS1022905643  |k 0/910000/  |k 1/910000/911700/  |p 3 
998 |g 1070023892  |a Tabatabai, Julia  |m 1070023892:Tabatabai, Julia  |d 910000  |d 910500  |e 910000PT1070023892  |e 910500PT1070023892  |k 0/910000/  |k 1/910000/910500/  |p 2 
998 |g 1135936560  |a Doerflinger, Sylvie  |m 1135936560:Doerflinger, Sylvie  |d 910000  |d 911700  |e 910000PD1135936560  |e 911700PD1135936560  |k 0/910000/  |k 1/910000/911700/  |p 1  |x j 
999 |a KXP-PPN1566831946  |e 2991605774 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"part":{"volume":"1","issue":"5","year":"2016","text":"1(2016,5) Artikel-Nummer e00219-16, 6 Seiten"},"title":[{"title":"mSphere","title_sort":"mSphere"}],"disp":"Development of a nanobody-based lateral flow immunoassay for detection of human norovirusmSphere","physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2844248-9"],"eki":["845748807"],"issn":["2379-5042"]},"language":["eng"],"recId":"845748807","origin":[{"publisher":"American Society for Microbiology","dateIssuedDisp":"[2016]-","publisherPlace":"Washington, DC"}],"note":["Gesehen am 15.06.21"],"pubHistory":["Volume 1, issue 1 (January/February 2016)-"]}],"recId":"1566831946","note":["Gesehen am 03.01.2018"],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"12 October 2016"}],"id":{"doi":["10.1128/mSphere.00219-16"],"eki":["1566831946"]},"person":[{"display":"Doerflinger, Sylvie","given":"Sylvie","role":"aut","family":"Doerflinger"},{"display":"Tabatabai, Julia","given":"Julia","role":"aut","family":"Tabatabai"},{"role":"aut","given":"Paul","display":"Schnitzler, Paul","family":"Schnitzler"},{"given":"Anna D.","display":"Koromyslova, Anna D.","role":"aut","family":"Koromyslova"},{"family":"Hansman","display":"Hansman, Grant S.","given":"Grant S.","role":"aut"}],"title":[{"title":"Development of a nanobody-based lateral flow immunoassay for detection of human norovirus","title_sort":"Development of a nanobody-based lateral flow immunoassay for detection of human norovirus"}],"language":["eng"],"name":{"displayForm":["Sylvie Y. Doerflinger, Julia Tabatabai, Paul Schnitzler, Carlo Farah, Steffen Rameil, Peter Sander, Anna Koromyslova, Grant S. Hansman"]},"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a DOERFLINGEDEVELOPMEN1220